TransEnterix to Participate in Two Upcoming Virtual Healthcare Conferences

Rhea-AI Summary

TransEnterix, Inc. (NYSE American: TRXC) announced that CEO Anthony Fernando and CFO Shameze Rampertab will speak at two upcoming virtual investor conferences. The presentations include:

• H.C. Wainwright BioConnect 2021 Conference on-demand from January 11, 2021, at 6:00 AM ET.
• Digital Surgery Panel at Westwicke/ICR Conference on January 14, 2021, at 10:00 AM ET.
• Presentation at Westwicke/ICR Conference on January 14, 2021, at 3:15 PM ET.

Webcasts are accessible on the company’s investor relations page for 90 days.

TransEnterix, Inc. (NYSE American: TRXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will present at two upcoming virtual investor conferences:

• Presentation at the H.C. Wainwright BioConnect 2021 Conference available for on-demand listening beginning Monday, January 11, 2021, at 6:00 am Eastern Time.
• Digital Surgery Panel presentation at the Westwicke/ICR Conference 2021 on Thursday, January 14, 2021 at 10:00 am Eastern Time. The panel will be moderated by Ryan Zimmerman, Managing Director, Equity Research - Medical Technology at BTIG.
• Presentation at the Westwicke/ICR Conference 2021 on Thursday, January 14, 2021 at 3:15 pm Eastern Time.

The on-demand H.C. Wainwright BioConnect 2021 conference presentation and the live audio webcast of the ICR conference presentations will be available online at the investor relations page of the Company’s website at http://ir.transenterix.com/events.cfm. Replays of the webcasts will be archived on the website for approximately 90 days.

About TransEnterix

At TransEnterix, Inc., we are digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through a new category of care called Digital Laparoscopy. Digitizing the interface enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and allows us to address the current clinical, cognitive and economic shortcomings in surgery. The system features the first machine vision system for use in robotic surgery which is powered by the new Intelligent Surgical Unit™ (ISU™) that enables augmented intelligence in surgery. The Senhance Surgical System brings the benefits of Digital Laparoscopy to patients around the world while staying true to the principles of value-based healthcare. Learn more about Digital Laparoscopy with the Senhance Surgical System here: https://Senhance.com/. Now available for sale in the US, the EU, Japan, and select other countries. For a complete list of indications for use, please visit: https://www.transenterix.com/indications-for-use/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005097/en/

FAQ

When will TransEnterix present at the H.C. Wainwright BioConnect 2021 Conference?

TransEnterix will present at the H.C. Wainwright BioConnect 2021 Conference on-demand starting January 11, 2021, at 6:00 AM ET.

What time is the Digital Surgery Panel at the Westwicke/ICR Conference 2021?

The Digital Surgery Panel will take place on January 14, 2021, at 10:00 AM ET.

What are the times for the presentations at the Westwicke/ICR Conference 2021?

TransEnterix's presentations at the Westwicke/ICR Conference are scheduled for January 14, 2021, at 10:00 AM ET and 3:15 PM ET.

How can I access the webcasts of TransEnterix's presentations?

Webcasts of the presentations can be accessed on TransEnterix's investor relations page and will be available for approximately 90 days.

What is the focus of TransEnterix's Digital Laparoscopy technology?

TransEnterix's Digital Laparoscopy technology aims to enhance minimally invasive surgery using augmented intelligence and robotics.